Flagship VentureLabs IV LLC 13D/13G Filings for Seres Therapeutics, Inc. (MCRB)

Flagship VentureLabs IV LLC 13D and 13G filings for Seres Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-07-07
5:00 pm
Purchase
2022-07-0513DSeres Therapeutics, Inc.
MCRB
Flagship VentureLabs IV LLC23,493,063
18.900%
8,443,072increase
(+56.10%)
Filing
2020-11-25
4:30 pm
Sale
2020-11-2313DSeres Therapeutics, Inc.
MCRB
Flagship VentureLabs IV LLC15,049,991
16.500%
-6,596,914decrease
(-30.48%)
Filing